ROSEN, A LEADING AND RANKED FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

AI Briefing

• – Investors in Mereo BioPharma Group plc's ADSs may have losses due to alleged securities fraud.
• – Rosen Law Firm is investigating a potential securities class action.
• – Investors have until April 6, 2026 to file their claims.